Significance of platelet-reactive antibody screening for patients facing frequent platelet transfusions Cover

.blurhash-client-img { display: none !important; }

Significance of platelet-reactive antibody screening for patients facing frequent platelet transfusions

Immunohematology

Volume 18 (2002): Issue 4 (December 2002)

By: T. Tasaki, K. Fujii, K. Gotoh, S. Satoh, J. Takadate, S. Sasaki, M. Tachibana and K. Yamamoto

Paid access

|Oct 2020

Figures & Tables

Access Required

This content requires purchase or subscription access.

DOI: https://doi.org/10.21307/immunohematology-2019-525 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X

Journal RSS Feed

Language: English

Page range: 104 - 108

Published on: Oct 14, 2020

Published by: American National Red Cross

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

platelet-reactive antibodies,

platelet transfusion,

platelet transfusion refractoriness,

platelet corrected count increment,

mixed passive hemagglutination,

nonhemolytic transfusion reaction,

lymphocytotoxic assay,

HLA-matched platelets

Related subjects:

Clinical medicine,

Laboratory medicine

© 2020 T. Tasaki, K. Fujii, K. Gotoh, S. Satoh, J. Takadate, S. Sasaki, M. Tachibana, K. Yamamoto, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous article Volume 18 (2002): Issue 4 (December 2002)Next article